18591-82-7 Usage
General Description
3-Amino-6-Methylpyridazine is a chemical compound identified by the CAS Number of 3430-13-5. It appears as a white crystal with a slight odor and is soluble in water. It is primarily used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff applications. This chemical, due to its potentially harmful effects, should be properly handled and stored. It can pose hazards if ingested, inhaled, or if it contacts the skin or eyes. Safety precautions should be observed when using 3-Amino-6-Methylpyridazine to prevent toxic exposure and environmental pollution. As with all chemicals, it should be disposed of in accordance with local, regional, national and international regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 18591-82-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,5,9 and 1 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 18591-82:
(7*1)+(6*8)+(5*5)+(4*9)+(3*1)+(2*8)+(1*2)=137
137 % 10 = 7
So 18591-82-7 is a valid CAS Registry Number.
InChI:InChI=1/C4H4IN3/c5-3-1-2-4(6)8-7-3/h1-2H,(H2,6,8)
18591-82-7Relevant articles and documents
-
Golodova et al.
, (1972)
-
IMIDAZOPYRIDAZINE COMPOUNDS
-
Page/Page column 25, (2008/06/13)
The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I): pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.
N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
-
, (2008/06/13)
The invention concerns pharmaceutically useful N-heterocyclyl sulphonamide derivatives, their pharmaceutically acceptable salts, processes for their manufacture, their use for antagonising one or more actions of endothelin in a human or other warm-blooded animal, their use in methods of treatment of diseases or medical conditions in which elevated or abnormal levels of endothelin play a significant causative role.
